Search Results - "Zivin, J A"

Refine Results
  1. 1

    Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study by GOLDSTEIN, L. B, AMARENCO, P, SZAREK, M, CALLAHAN, A, HENNERICI, M, SILLESEN, H, ZIVIN, J. A, WELCH, K. M. A

    Published in Neurology (10-06-2008)
    “…In the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study, atorvastatin 80 mg/day reduced the risk of stroke in patients with…”
    Get full text
    Journal Article
  2. 2

    Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes by Lapchak, P.A, Maher, P, Schubert, D, Zivin, J.A

    Published in Neuroscience (12-12-2007)
    “…Abstract The present study assessed whether baicalein (5,6,7-trihydroxyflavone), a polyphenolic antioxidant 12/15-lipoxygenase inhibitor would attenuate…”
    Get full text
    Journal Article
  3. 3

    Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: An extended therapeutic window study using continuous and pulse frequency delivery modes by Lapchak, P.A, Salgado, K.F, Chao, C.H, Zivin, J.A

    Published in Neuroscience (21-09-2007)
    “…Abstract Photon or near-infrared light therapy (NILT) may be an effective neuroprotective method to reduce behavioral dysfunction following an acute ischemic…”
    Get full text
    Journal Article
  4. 4

    Prospective reliability of the STRokE DOC wireless/site independent telemedicine system by MEYER, B. C, LYDEN, P. D, AL-KHOURY, L, CHENG, Y, RAMAN, R, FELLMAN, R, BEER, J, RAO, R, ZIVIN, J. A

    Published in Neurology (22-03-2005)
    “…The authors evaluated a site-independent telemedicine system. Telemedicine may be limited by the need for fixed connectivity. Wireless and site-independent…”
    Get full text
    Journal Article
  5. 5

    Factors determining the therapeutic window for stroke by ZIVIN, J. A

    Published in Neurology (01-03-1998)
    “…The duration of the window to treat acute cerebral ischemia has become an important question since the first effective drug for stroke victims has become…”
    Get full text
    Journal Article
  6. 6

    Persistent phosphorylation of cyclic amp responsive element-binding protein and activating transcription factor-2 transcription factors following transient cerebral ischemia in rat brain by Hu, B.R., Fux, C.M., Martone, M.E., Zivin, J.A., Ellisman, M.H.

    Published in Neuroscience (01-03-1999)
    “…The transcription factors cyclic AMP responsive element-binding protein (CREB) and activating transcription factor-2 were studied in rat brains subjected to 15…”
    Get full text
    Journal Article
  7. 7

    Thrombolytic stroke therapy: Past, present, and future by ZIVIN, J. A

    Published in Neurology (13-07-1999)
    “…Until 1995, treatment of strokes consisted exclusively of efforts to prevent recurrence. Proof that tissue plasminogen activator is useful for acute management…”
    Get full text
    Journal Article
  8. 8

    The STRokE DOC trial technique: 'video clip, drip, and/or ship' by Meyer, B. C., Raman, R., Rao, R., Fellman, R. D., Beer, J., Werner, J., Zivin, J. A., Lyden, P. D.

    Published in International journal of stroke (01-11-2007)
    “…Rationale To describe the clinical trial methods of a site-independent telemedicine system used in stroke. Aims A lack of readily available stroke expertise…”
    Get full text
    Journal Article
  9. 9

    Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke by del Zoppo, G J, Poeck, K, Pessin, M S, Wolpert, S M, Furlan, A J, Ferbert, A, Alberts, M J, Zivin, J A, Wechsler, L, Busse, O

    Published in Annals of neurology (01-07-1992)
    “…An open angiography-based, dose rate escalation study on the effect of intravenous infusion of recombinant tissue plasminogen activator (rt-PA) on cerebral…”
    Get more information
    Journal Article
  10. 10

    Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule by CLARK, W. M, MADDEN, K. P, ROTHLEIN, R, ZIVIN, J. A

    Published in Journal of neurosurgery (01-10-1991)
    “…Activated leukocytes appear to be directly involved in potentiating ischemic central nervous system (CNS) injury. Adhesion of leukocytes to endothelium is…”
    Get full text
    Journal Article
  11. 11

    Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy by BOWES, M. P, ROTHLEIN, R, FAGAN, S. C, ZIVIN, J. A

    Published in Neurology (01-04-1995)
    “…We evaluated the ability of monoclonal antibodies directed against leukocyte adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], CD18) to enhance…”
    Get full text
    Journal Article
  12. 12

    Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model by Bowes, M P, Zivin, J A, Rothlein, R

    Published in Experimental neurology (01-02-1993)
    “…We evaluated the effect of antibodies directed against a leukocyte adhesion molecule (ICAM-1) in an embolic model of stroke followed by thrombolysis with…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Quantal bioassay and stroke by ZIVIN, J. A, WAUD, D. R

    Published in Stroke (1970) (01-05-1992)
    “…Experimental investigation of stroke, in particular the evaluation of therapeutic maneuvers, is difficult because even well-controlled experiments show…”
    Get full text
    Journal Article
  16. 16

    Detection of arterial emboli using Doppler ultrasound in rabbits by Russell, D, Madden, K P, Clark, W M, Sandset, P M, Zivin, J A

    Published in Stroke (1970) (01-02-1991)
    “…The purpose of this study was to develop an animal model that could be used to test the ability of Doppler ultrasound to detect arterial emboli composed of…”
    Get full text
    Journal Article
  17. 17

    Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats by Aronowski, J, Ostrow, P, Samways, E, Strong, R, Zivin, J A, Grotta, J C

    Published in Stroke (1970) (01-11-1994)
    “…This study explored the correlation between duration of focal ischemia and infarct volume in spontaneously hypertensive rats as a measure of outcome after…”
    Get full text
    Journal Article
  18. 18

    Neuroprotective therapies in stroke by Zivin, J A

    Published in Drugs (New York, N.Y.) (1997)
    “…Neuroprotective drugs are known to reduce neurological damage in animal models of stroke, but none are generally accepted for the treatment of patients with…”
    Get full text
    Journal Article
  19. 19

    Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment by CLARK, W. M, MADDEN, K. P, ROTHLEIN, R, ZIVIN, J. A

    Published in Stroke (1970) (01-07-1991)
    “…Activated leukocytes appear to be directly involved in ischemic central nervous system injury. A surface glycoprotein (CD18) on the leukocyte is required for…”
    Get full text
    Journal Article
  20. 20

    Prosaptide exacerbates ischemia-induced behavioral deficits in vivo; an effect that does not involve mitogen-activated protein kinase activation by Lapchak, P.A, Araujo, D.M, Shackelford, D.A, Zivin, J.A

    Published in Neuroscience (01-01-2000)
    “…Prosaposin is a 517 amino acid membrane component and secreted protein 5,7,9 that is proteolytically cleaved to generate the four small glycoproteins; saposins…”
    Get full text
    Journal Article